1887

Abstract

Summary.

Anti-lipopolysaccharide equine hyperimmune plasma (anti-LPS), which has been used successfully to treat LPS (endotoxin)-mediated disorders, has been further characterised. IgG present in anti-LPS had the highest affinity for LPS prepared from and and intermediate affinity for O55:B5, O127:B8 and . Anti-LPS destroyed by means of complement activation a wide range of gram-negative bacteria, including various species and strains of . Control plasmas or saline had little or no effect. Maximum killing occurred within seconds to minutes. Electronmicroscopy showed that anti-LPS treatment of caused extensive cell wall and cytoplastic membrane disruption, followed by the appearance of spheroplasts and cell ghosts. Antibodies were required in 100 000-fold excess to inhibit the limulus amoebocyte lysate reaction with LPS from . Anti-LPS thus contains IgG that binds to a wide range of LPS, and can destroy a wide range of gram-negative bacteria by means of complement activation.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-24-3-187
1987-11-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/24/3/medmicro-24-3-187.html?itemId=/content/journal/jmm/10.1099/00222615-24-3-187&mimeType=html&fmt=ahah

References

  1. Cohen J, McConnell J S. 1984; Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. Journal of Infectious Diseases 150:916–924
    [Google Scholar]
  2. Collins M S, Roby R E. 1983; Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice. Journal of Trauma 23:530–534
    [Google Scholar]
  3. Conradie J D, Gray R, Mbhele B E. 1980; Serum alphafetoprotein determination by enzyme linked immunosorbent assay. South African Medical Journal 58:169–171
    [Google Scholar]
  4. Du Bose D A, Lemaire M, Basamania K, Rowlands J. 1980; Comparison of plasma extraction techniques in preparation of samples for endotoxin testing by the limulus amebocyte lysate test. Journal of Clinical Microbiology 11:68–72
    [Google Scholar]
  5. Duswald K H, Jochum M, Fritz H. 1982; Pathophysiology and pathobiochemistry of sepsis and septic shock. Intensive Care 2:1–6
    [Google Scholar]
  6. Elin R J. 1979; Clinical utility of the limulus test with blood CSF and synovial fluid. Cohen E. Biomedical applications of the horseshoe crab. (Progress in clinical and biological research 24 Alan R Liss; New York:279–292
    [Google Scholar]
  7. Engvall E, Perlmann P. 1972; Enzyme linked immunosorbent assay ELISA. III. Quantitation of specific antibodies by enzyme-labelled anti-immunoglobulin in antigen-coated tubes. Journal of Immunology 109:129–135
    [Google Scholar]
  8. Gaffin S L. 1983a; Control of septic shock—present day concept. South African Journal of Hospital Medicine 8:4–11
    [Google Scholar]
  9. Gaffin S L. 1983b; Large scale production of anti-gram-negative bacterial antibodies. Lancet 2:1420–1421
    [Google Scholar]
  10. Gaffin S L, Badsha N, Vorster B J. 1985a; Properties of human antilipopolysaccharide gamma globulin : specificity and protective effects. Vox Sanguinis 48:276–283
    [Google Scholar]
  11. Gaffin S. L, Badsha N, Brock-Utne J G, Vorster B J, Conradie J D. 1982a; An ELISA procedure for detecting human anti-endotoxin antibodies in serum. Annals of Clinical Biochemistry 19:191–194
    [Google Scholar]
  12. Gaffin S L, Baker B, Du Preez J, Katzwinkel J, Fleming J, Brock-Utne J G. 1982b; Prophylaxis and therapy with anti-endotoxin hyperimmune serum against gastroenteritis and endotoxemia in horses. Milne J. Proceedings of the 28th Annual convention of the American Association of Equine PractitionersAtlanta335–340
    [Google Scholar]
  13. Gaffin S, Brock-Utne J G, Zanotti A, Wells M T. 1986; Hypoxia-induced endotoxaemia in primates : role of reticuloendoth-elial system function and anti-lipopolysaccharide plasma. Aviation Space and Environmental Medicine 57:1044–1049
    [Google Scholar]
  14. Gaffin S L, Grinberg Z, Abraham C, Birkhan J, Schechter Y. 1981; Protection against hemorrhagic shock in the cat by human plasma containing endotoxin specific antibodies. Journal of Surgical Research 31:18–21
    [Google Scholar]
  15. Gaffin S L. 1982c; Antibiotic effect of human and equine anti-endotoxin antibody rich serum on Klebsiella pneumoniae . South African Journal of Science 78:91–92
    [Google Scholar]
  16. Gaffin S L, Wells M, Jordaan J P. 1985b; Anti-lipopolysaccharide toxin therapy for whole bodyX-irradiation overdose. British Journal of Radiology 58:881–884
    [Google Scholar]
  17. Gathiram P, Gaffin S L, Wells M T, Brock-Utne J G. 1986; Superior mesenteric artery occlusion shock in cats. Modification of the endotoxemia by anti-lipopolysaccharide antibodies (Anti-LPS). Circulatory Shock 19:231–237
    [Google Scholar]
  18. Johnson K J, Ward P A, Goralnick S, Osborn M J. 1977; Isolation from human serum of an inactivator of bacterial lipopoly-saccharide. American Journal of Pathology 88:559–574
    [Google Scholar]
  19. Johnson K J, Ward P A. 1972; The requirement for serum complement in the detoxification of bacterial endotoxin. Journal of Immunology 108:611–616
    [Google Scholar]
  20. Lachman E, Pitsoe S. B., Gaffin S L. 1984a; Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin. Lancet 1:981–983
    [Google Scholar]
  21. Lachman E, Pitsoe S B, Gaffin S L. 1984b; Anti-lipopolysaccharide antibodies: update. Lancet 2:875–876
    [Google Scholar]
  22. Ng A K, Chen C H, Chang C M, Nowotny A. 1976; Relationship of structure to function in bacterial endotoxins : serologically cross-reactive components and their effect on protection of mice against some gram negative infections. Journal of General Microbiology 94:107–116
    [Google Scholar]
  23. Pegg S P, Amerena R, Tahir H M. 1982; Changing patterns of Pseudomonas aeruginosa antibiotic sensitivity. Burns including Thermal Injury 8:151–155
    [Google Scholar]
  24. Pudifin D, L’Hoste I, Duursma J, Gaffin S L. 1985; Opsonisation of gram-negative bacteria by anti-lipopolysaccharide antibodies. Lancet 2:1009–1010
    [Google Scholar]
  25. Roantree R J, Pappas N C. 1960; The survival of strains of enteric bacilli in the blood stream as related to their sensitivity to the bactericidal effect of serum. Journal of Clinical Investigation 39:82–88
    [Google Scholar]
  26. Shenep J L, Mogan K A. 1984; Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis. Journal of Infectious Diseases 150:380–388
    [Google Scholar]
  27. Smith P B, Tomfohrde K M, Rhoden D L, Balows A. 1972; API System: a multitude micromethod for identification of Enterobacteriaceae. Applied Microbiology 24:449–452
    [Google Scholar]
  28. Stiehm E R. 1979; Standard and special human immune serum globulins as therapeutic agents. Pediatrics 63:301–319
    [Google Scholar]
  29. Thomson M. 1983; The use of equine anti-endotoxin hyperimmune serum in the treatment of septic arthritis in foals. Journal of South African Veterinary Association 54:279–281
    [Google Scholar]
  30. Walker R I, Daily O P, Krasner R, Merrell B R, Porvaznik M. 1982; The relationship of enteric micro-organisms to causes of morbidity and mortality in operational situations. Military Medicine 147:15–22
    [Google Scholar]
  31. Wardle E N. 1975; Endotoxin and acute renal failure. Nephron 14:321–332
    [Google Scholar]
  32. Wells M T, Gaffin S L. 1986; A morphological study of the action of equine anti-lipopolysaccharide plasma on gram-negative bacteria. Journal of Medical Microbiology 24:165–168
    [Google Scholar]
  33. Welsh N H, Rauch A J, Gaffin S L. 1984; Topical immunotherapy for Pseudomonas keratitis in rabbits : use of antilipopolysaccharide plasma. British Journal of Ophthalmology 68:828–832
    [Google Scholar]
  34. Wessels B C, Gaffin S L. 1986; Anti-endotoxin immunotherapy for canine parvovirus endotoxaemia. Journal of Small Animal Practice 27:609–615
    [Google Scholar]
  35. Wessels B C, Gaffin S L, Wells M T. 1986; Circulating plasma endotoxin (LPS) concentrations in healthy and hemorrhagic enteric dogs : anti-endotoxin immunotherapy in hemorrhagic enteric endotoxaemia. Journal of American Association of Small Animals (in press)
    [Google Scholar]
  36. Westphal O, Lüderitz O, Bister F. 1952; Uber die extraktion von bakterien mit phenol/wasser. Zeitscrift fur Naturforschung 7B:148–155
    [Google Scholar]
  37. Wildfeuer A, Heymer B, Schleifer K, Haferkamp O. 1974; Investigations on the specificity of the Limulus Test for the detection of endotoxin. Applied Microbiology 28:867–871
    [Google Scholar]
  38. Williams P, Lambert P A, Brown M R W, Jones R J. 1983; The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. Journal of General Microbiology 129:2181–2191
    [Google Scholar]
  39. Wilson M B, Nakane P K. 1978; Recent developments in the periodate method of conjugating horseradish peroxidase (HRPO) to antibodies. Knapp W. Immunofluorescence and related staining techniques Elsevier; Amsterdam:215–226
    [Google Scholar]
  40. Wilson L A, Spitznagel J K. 1968; Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems. Journal of Bacteriology 96:1339–1348
    [Google Scholar]
  41. Young L S. 1984; Monoclonal antibodies: technology and application to gram-negative infections. Infection 12:303–308
    [Google Scholar]
  42. Young L S. 1975; Opsonizing antibodies, host factors and the limulus assay for endotoxin. Infection and Immunity 12:88–92
    [Google Scholar]
  43. Zanotti A M, Gaffin S L. 1985; Prophylaxis of superior mesenteric artery occlusion shock in rabbits by antilipopolysaccharide (Anti-LPS) antibodies. Journal of Surgical Research 38:113–115
    [Google Scholar]
  44. Ziegler E J. 1982; Treatment of gram-negative bacteremia and shock with human anti serum to a mutant Escherichia coli . New England Journal of Medicine 307:1225–1230
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-24-3-187
Loading
/content/journal/jmm/10.1099/00222615-24-3-187
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error